MOLT-4 Cells
USD$395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Introduction to the MOLT-4 cell line
| Description | MOLT-4 is a T lymphoblast cell line derived from the peripheral blood of a 19-year-old male patient with Acute lymphoblastic leukemia (ALL) in relapse in 1971. It is a sister cell line of MOLT-3, while MOLT-4 shows an unusual T-cell antigen receptor gamma-chain gene (T-gamma) rearrangement. MOLT-4 cells have a doubling time of around 30 hours, grow in suspension, and are tumorigenic in untreated nude mice, anti-lymphocyte serum-treated mice, and x-irradiated mice. MOLT-4 cells have a hypertetraploid chromosome number with the modal chromosome number of 95 occurring in 24% of cells but show stable and recurrent structural abnormalities of chromosomes and longer telomere length. MOLT-4 expresses a variety of T cell markers including CD1, CD2, CD3A, CD3B, CD3C, CD4, CD5, CD6, and CD7. They also express high levels of terminal deoxynucleotidyl transferase (TdT). The MOLT-4 cell line does not produce immunoglobulin or Epstein-Barr virus. The patient from whom the cells were derived had received prior multidrug chemotherapy. There is a G -> A mutation at codon 248 of the p53 gene, and P53 is not expressed. The line was initially contaminated with mycoplasma but has since been cured with antibiotics. |
|---|---|
| Organism | Human |
| Tissue | Peripheral blood |
| Disease | Adult T acute lymphoblastic leukemia |
| Synonyms | Molt-4, MOLT 4, Molt 4, MOLT.4, MOLT4, Molt4, GM02219, GM02219C, GM2219C, GM02219D |
Specifications
| Age | 19 years |
|---|---|
| Gender | Male |
| Ethnicity | Caucasian |
| Morphology | Round cells |
| Cell type | T lymphocyte |
| Growth properties | Suspension |
Documentation
| Citation | MOLT-4 (Cytion catalog number 300115) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_0013 |
Genetic characteristics
| Protein expression | P53 positive |
|---|---|
| Antigen expression | CD1 (49%), CD2 (35%), CD3 A (26%) B (33%) C (34%), CD4 (55%), CD5 (72%), CD6 (22%), CD7 (77%) |
| Viruses | The cells do not produce immunoglobulin or Epstein-Barr virus (Minowada, 1972). |
| Products | High levels of terminal deoxynucleotidyl transferase (TdT) are produced |
| Mutational profile | G -> A mutation at codon 248 of the p53 gene, P53 is not expressed (Rodrigues, 1990). |
| Karyotype | Hypertetraploid. Modal number: 96. Two x and two Y chromosomes. |
Cell culturing methods
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Subculturing | Maintain cultures by periodically adding or replacing the medium. Initiate cultures with a density of 5 x 105 cells/ml and keep the cell concentration within the range of 3 x 105 to 1 x 106 cells/ml for optimal growth. |
| Seeding density | 1 x 105 cells/cm2 |
| Fluid renewal | 2 to 3 times per week |
| Post-Thaw Recovery | 24 to 48 hours |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality assurance of Molt 4 leukemia cells
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300115-200226 | Certificate of Analysis | 27. Mar. 2026 | 300115 |
| 300115-919 | Certificate of Analysis | 18. Aug. 2025 | 300115 |